-
Another study has shown an increase in mortality associated with the use of an oral IIb/IIIa receptor antagonist.
-
Prognostic Value of ABPMs in patients with Treated Hypertension;
Tazarotene Cream in the Treatment of Psoriasis; Antihyperglycemic
Effect of Oolong Tea in Type 2 Diabetes; Metformin and
Thiazolidinedione Use in Medicare Patients with Heart Failure; Alcohol
Consumption Patterns and Biologic Markers of Glycemic Control; Azelaic
Acid Gel as a New Treatment for Papulopustular Rosacea
-
The non-ergot dopamine agonists ropinirole and pramipexole effectively ameliorate the cardinal motor features of idiopathic Parkinsons disease.
-
The present report from the International Study of Unruptured Intracranial Aneurysms is the largest prospective analysis of the risk of rupture of unruptured asymptomatic cerebral aneurysm.
-
Intravenous immunoglobulin (IVIg) is an effective treatment for a wide range of autoimmune neurological disorders. IVIg is well tolerated in general but may rarely result in anaphylaxis and acute renal failure, as well as thromboembolic complications such as pulmonary embolism and stroke. These recent reports in Neurology highlight the potential vascular consequences of IVIg.
-
Differentiating central from peripheral causes of vertigo is a recurrent clinical challenge that behooves reinforcement.
-
Part I of this two-part series covered gastrointestinal causes of chest pain and aortic dissection. This second and final part of the series will focus on pulmonary, psychiatric, and musculoskeletal causes of chest pain.
-
-
Elevated homocysteine levels have been associated with atherosclerosis. Folic acid supplementation is a simple, inexpensive way to reduce homocysteine levels, which has become popular for secondary prevention in patients with coronary artery disease (CAD), despite a paucity of long-term clinical trial data. Thus, Liem and colleagues studied 593 patients with stable CAD on statins who were randomized to open-label folic acid 0.5 mg/d or standard care, which included aggressive pursuit of lipid goals.
-
In 1998, Beyth and colleagues developed a modified outpatient bleeding risk index. In this prospective study conducted at the University of Ottawa, 222 patients with diagnosed pulmonary embolism or deep venous thrombosis were observed for an average of 18.5 months.
